Does Seasonal Influenza Vaccine Increase Risk for Guillain-Barré Syndrome?
Researchers determined the risk for Guillain-Barré Syndrome following seasonal influenza vaccination in a real-world study.
Vaccination
Abatacept Maintains Effective Diphtheria/Tetanus Vaccination Protection in Polyarticular-Course JIA
Researchers assessed protective antibody responses to diphtheria and tetanus vaccination in patients with polyarticular-course juvenile idiopathic arthritis.
Addressing Parents’ Concerns Improves Influenza Immunization Rates
Implementation of an influenza immunization program increased vaccinations rates from 44% to 57% the following year.
Hepatitis B Vaccination Booster Dose After 18 Years Maintains Long-Term Protection
Primary vaccination against hepatitis B virus (HBV) at birth may not provide adequate lifelong antibody levels, but a booster vaccine at age 18 years reinforces antibody levels for at least 4 more years.
CMV Vaccine May Prevent Viremia in Hematopoietic Stem Cell Transplant Recipients
Triplex, a modified recombinant attenuated poxvirus vaccine engineered to induce a virus-specific T-cell response to control CMV in recipients of allogeneic hematopoietic stem cell transplant was safe and well tolerated.
Double-Dose Influenza Vaccine Doses May Not Benefit Pregnant Women With HIV
A double-dose of inactivated influenza vaccine may not increase the immunogenicity of the vaccine among pregnant women with HIV.
Hexavalent Vaccine Included in Pediatric Vaccination Program
The DTaP-IPV-Hib-HepB vaccine has safety profile consistent with licensed comparator vaccines and has been included in the federal Vaccines for Children program.
ACIP Updates Recommendations for Tdap Vaccination
Updated recommendations for the use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine have been developed by the Advisory Committee on Immunization Practices (ACIP).
ACIP: 2020 Child and Adolescent Immunization Schedule Updates
The ACIP has released an updated version of the child and adolescent immunization schedule for ages 18 years and younger in the United States.
Intradermal Rabies Vaccine Noninferior to Intramuscular Vaccine
Intradermal administration of the rabies vaccine may produce similar antibody titers at a fraction of the intramuscular administration dose.
Next post in Vector-borne Illnesses
